Earnings Call · Q1 FY2023·2023-05-12

Q1 23EPS -4.76%·Rev n/aQ4 22EPS -5.00%·Rev n/aQ3 22EPS -13.64%·Rev n/aQ2 22EPS -18.94%·Rev n/a⚠ consensus missing

Longeveron Inc. LGVN

James Clavijo — Chief Financial Officer

Wa'el Hashad — Chief Executive Officer

Chris Min — Chief Medical Officer

−4.3%1d on move date−4.2% vs SPY3d−13.6%5d−8.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LGVN calls or request research access.

More LGVN calls Browse calls Request research access